Daniel Gabbay Biography and Net Worth

Executive Vice President and Chief Financial Officer of Healthcare Realty Trust

Mr. Gabbay joined the Company as Executive Vice President and Chief Financial Officer in January 2026. Most recently, he served as a Managing Director in the Real Estate Investment Banking Group at RBC Capital Markets, where he focused on the healthcare REIT sector, and previously held a similar role in the Real Estate Investment Banking Group at Barclays. Mr. Gabbay has nearly 20 years of experience providing advisory and capital markets services to clients across the real estate industry. He began his career in investment banking at Lehman Brothers in 2001.

Mr. Gabbay holds a Masters in Business Administration from Harvard Business School, a Bachelor of Science from The Wharton School and a Bachelor of Arts from the University of Pennsylvania.

What is Daniel Gabbay's net worth?: The estimated net worth of Daniel Gabbay is at least $183.80 as of March 4th, 2026. Mr. Gabbay owns 10 shares of Healthcare Realty Trust stock worth more than $184 as of March 5th. This net worth estimate does not reflect any other assets that Mr. Gabbay may own. Learn More about Daniel Gabbay's net worth.
How do I contact Daniel Gabbay?: The corporate mailing address for Mr. Gabbay and other Healthcare Realty Trust executives is 3310 WEST END AVE SUITE 700, NASHVILLE TN, 37203. Healthcare Realty Trust can also be reached via phone at (615) 269-8175 and via email at [email protected]. Learn More on Daniel Gabbay's contact information.
Has Daniel Gabbay been buying or selling shares of Healthcare Realty Trust?: Over the course of the past ninety days, Daniel Gabbay has bought $187.40 in shares of Healthcare Realty Trust stock. Most recently, on Wednesday, March 4th, Daniel Gabbay bought 10 shares of Healthcare Realty Trust stock. The stock was acquired at an average cost of $18.74 per share, with a total value of $187.40. Following the completion of the transaction, the executive vice president now directly owns 10 shares of the company's stock, valued at $187.40. Learn More on Daniel Gabbay's trading history.
Who are Healthcare Realty Trust's active insiders?: Healthcare Realty Trust's insider roster includes Edward Braman (Director), John Bryant, Jr. (EVP), Daniel Gabbay (Executive Vice President and Chief Financial Officer), Robert Hull (EVP), Peter Lyle, Sr. (Director), John Singleton (Director), and Julie Wilson (EVP). Learn More on Healthcare Realty Trust's active insiders.
Are insiders buying or selling shares of Healthcare Realty Trust?: In the last twelve months, Healthcare Realty Trust insiders bought shares 3 times. They purchased a total of 12,510 shares worth more than $201,562.40. In the last twelve months, insiders at the real estate investment trust sold shares 1 times. They sold a total of 15,000 shares worth more than $270,000.00. The most recent insider tranaction occured on March, 4th when EVP Daniel Gabbay bought 10 shares worth more than $187.40. Insiders at Healthcare Realty Trust own 0.4% of the company. Learn More about insider trades at Healthcare Realty Trust.
Information on this page was last updated on 3/4/2026.

Daniel Gabbay Insider Trading History at Healthcare Realty Trust

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/4/2026	Buy	10	$18.74	$187.40	10

Daniel Gabbay Buying and Selling Activity at Healthcare Realty Trust

Healthcare Realty Trust Company Overview

Healthcare Realty Trust, Inc. provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R. Emery in 1992 and is headquartered in Nashville, TN.

Today's Range

Now: $18.41

$18.16

$18.65

50 Day Range

MA: $17.38

$16.34

$18.81

2 Week Range

Now: $18.41

$14.09

$18.97

Volume

2,819,143 shs

Average Volume

3,842,347 shs

Market Capitalization

$6.42 billion

P/E Ratio

N/A

Dividend Yield

5.21%

Beta

0.96